Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Enhabit, Inc ( (EHAB) ) has provided an update.
Enhabit reported fourth-quarter 2025 net service revenue of $270.4 million and an 11.6% year-on-year increase in consolidated adjusted EBITDA to $28 million, despite a net loss of $38.7 million driven in part by goodwill impairment. Operationally, the company posted solid growth in home health and hospice patient volumes, lowered home health cost per patient day, opened 10 de novo sites in 2025, and continued to reduce bank debt and interest expense, signaling improved cash generation and balance-sheet resilience.
The company highlighted a pending acquisition by private equity firm Kinderhook Industries for $13.80 per share in cash, valuing Enhabit at about $1.1 billion and expected to close in the second quarter of 2026, subject to customary approvals. In connection with the transaction and its strategic transition, Enhabit amended and extended its credit facilities to 2031, suspended earnings calls and guidance, and maintained its focus on admissions growth and margin improvement in both home health and hospice segments.
The most recent analyst rating on (EHAB) stock is a Hold with a $13.80 price target. To see the full list of analyst forecasts on Enhabit, Inc stock, see the EHAB Stock Forecast page.
Spark’s Take on EHAB Stock
According to Spark, TipRanks’ AI Analyst, EHAB is a Neutral.
Enhabit, Inc’s overall stock score is driven by mixed financial performance, with profitability challenges offset by strong cash flow improvements. Technical indicators show positive momentum, while valuation remains a concern due to negative earnings. The earnings call and corporate events provide optimism with strategic growth initiatives and improved financial guidance, but potential regulatory risks remain.
To see Spark’s full report on EHAB stock, click here.
More about Enhabit, Inc
Enhabit, Inc., based in Dallas, is a leading U.S. provider of home health and hospice care services, focusing on Medicare and non-Medicare patients across its branch network. The company emphasizes growing its patient census, expanding de novo locations, and managing costs and leverage to strengthen its balance sheet and support future investment.
Average Trading Volume: 1,050,055
Technical Sentiment Signal: Buy
Current Market Cap: $689.8M
See more insights into EHAB stock on TipRanks’ Stock Analysis page.

